Seelos Therapeutics, Inc. Cash Flow Quality Index
Latest as of June 2024:
-0.57x
Seelos Therapeutics, Inc. cash flow quality index. Seelos Therapeutics, Inc. (SEELQ) has a Cash Flow Quality Index of -0.57x as of June 2024. Operating cash flow of $-972.00K is below net income of $1.71 Million, suggesting accrual-heavy earnings not yet converted to cash. See Seelos Therapeutics, Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.57x
Operating CF / Net Income
Operating Cash Flow
$-972.00K
USD
Net Income
$1.71 Million
USD
Data as of
Jun 2024
Most recent filing
Seelos Therapeutics, Inc. Cash Flow Quality Index by Year (None–None)
Seelos Therapeutics, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Seelos Therapeutics, Inc.. For the full cash flow conversion analysis, see SEELQ cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.